{"success":true,"data":{"pressRelease":{"id":"106732","rtpr_id":"nNFC6q0B52","ticker":"ADMA","exchange":"NASDAQ","all_tickers":["ADMA"],"title":"ADMA INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of the August 10, 2026 Lead Plaintiff Deadline ADMA Biologics, Inc. Securities Class Action","author":"Newsfile Corp","published_at":"2026-08-03T19:28:46.064Z","article_body":"Atlanta, Georgia--(Newsfile Corp. - August 3, 2026) - A shareholder class\naction lawsuit has been filed against ADMA Biologics, Inc. (\"ADMA\") (NASDAQ:\nADMA). The lawsuit alleges that Defendants made false and misleading\nstatements and/or failed to disclose material adverse facts regarding ADMA's\nbusiness, operations, and prospects, including allegations that: (1) ADMA\nengaged in an undisclosed related party transaction; (2) ADMA used channel\nstuffing to create an appearance of revenue; and (3) ADMA lacked adequate\ninternal controls.\n\nIf you purchased ADMA shares between August 9, 2024 and March 25, 2026, and\nexperienced a loss on that investment, you are encouraged to discuss your\nlegal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by\ntoll-free telephone at (888) 508-6832, or by visiting the firm's website at\nwww.holzerlaw.com/case/adma-biologics/ for more information.\n\nThe deadline to ask the court to be appointed lead plaintiff in the case is\nAugust 10, 2026.\n\nHolzer & Holzer, LLC, an ISS top rated securities litigation law firm for\n2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation\nof shareholders and investors in litigation nationwide, including shareholder\nclass action and derivative litigation. Since its founding in 2000, Holzer &\nHolzer attorneys have played critical roles in recovering hundreds of millions\nof dollars for shareholders victimized by fraud and other corporate\nmisconduct. More information about the firm is available through its\nwebsite, www.holzerlaw.com, and upon request from the firm. Holzer &\nHolzer, LLC has paid for the dissemination of this promotional communication,\nand Corey Holzer is the attorney responsible for its content. \n\nCONTACT:\nCorey D. Holzer, Esq.\n(888) 508-6832 (toll-free)\ncholzer@holzerlaw.com\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/307733","article_body_html":"","raw_payload":{"data":{"id":"nNFC6q0B52","title":"ADMA INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of the August 10, 2026 Lead Plaintiff Deadline ADMA Biologics, Inc. Securities Class Action","author":"Newsfile Corp","ticker":"ADMA","created":"2026-08-03T19:28:46.064Z","tickers":["ADMA"],"exchange":"NASDAQ","article_body":"Atlanta, Georgia--(Newsfile Corp. - August 3, 2026) - A shareholder class\naction lawsuit has been filed against ADMA Biologics, Inc. (\"ADMA\") (NASDAQ:\nADMA). The lawsuit alleges that Defendants made false and misleading\nstatements and/or failed to disclose material adverse facts regarding ADMA's\nbusiness, operations, and prospects, including allegations that: (1) ADMA\nengaged in an undisclosed related party transaction; (2) ADMA used channel\nstuffing to create an appearance of revenue; and (3) ADMA lacked adequate\ninternal controls.\n\nIf you purchased ADMA shares between August 9, 2024 and March 25, 2026, and\nexperienced a loss on that investment, you are encouraged to discuss your\nlegal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by\ntoll-free telephone at (888) 508-6832, or by visiting the firm's website at\nwww.holzerlaw.com/case/adma-biologics/ for more information.\n\nThe deadline to ask the court to be appointed lead plaintiff in the case is\nAugust 10, 2026.\n\nHolzer & Holzer, LLC, an ISS top rated securities litigation law firm for\n2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation\nof shareholders and investors in litigation nationwide, including shareholder\nclass action and derivative litigation. Since its founding in 2000, Holzer &\nHolzer attorneys have played critical roles in recovering hundreds of millions\nof dollars for shareholders victimized by fraud and other corporate\nmisconduct. More information about the firm is available through its\nwebsite, www.holzerlaw.com, and upon request from the firm. Holzer &\nHolzer, LLC has paid for the dissemination of this promotional communication,\nand Corey Holzer is the attorney responsible for its content. \n\nCONTACT:\nCorey D. Holzer, Esq.\n(888) 508-6832 (toll-free)\ncholzer@holzerlaw.com\n\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/307733"},"type":"article","timestamp":"2026-08-03T19:28:46.117015391Z","server_sent_at_ms":1785785326117},"received_at":"2026-08-03T19:28:46.168Z","source_url":"https://www.newsfilecorp.com/release/307733"},"analysis":{"id":"95744","press_release_id":"106732","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"legal_litigation","narrative":"Holzer & Holzer, LLC issued a shareholder-solicitation notice naming ADMA Biologics, Inc. regarding a securities class action lawsuit. The firm alleges false statements regarding undisclosed related party transactions and channel stuffing.\n\nThe release is a routine lead-plaintiff-deadline reminder, encouraging investors who suffered losses between August 2024 and March 2026 to contact the firm.\n\nThis is a paid promotional communication from a plaintiff law firm, not an issuer disclosure or a certified court action. Treat as low-signal noise.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":null,"quotedText":"","namedEntities":{"people":[{"name":"Corey D. Holzer","role":"Attorney"}],"products":[],"companies":[{"name":"ADMA Biologics, Inc.","ticker":"ADMA"},{"name":"Holzer & Holzer, LLC","relationship":"plaintiff law firm"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm shareholder solicitation issued by Holzer & Holzer, LLC. No new disclosure from the issuer; no certified class, no settlement. Boilerplate lead-plaintiff-deadline reminder."},"tickerRelevance":{"others":[],"primary":"ADMA"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Holzer & Holzer, LLC issued a shareholder-solicitation notice naming ADMA Biologics, Inc. regarding a securities class action lawsuit. The firm alleges false statements regarding undisclosed related party transactions and channel stuffing.\n\nThe release is a routine lead-plaintiff-deadline reminder, encouraging investors who suffered losses between August 2024 and March 2026 to contact the firm.\n\nThis is a paid promotional communication from a plaintiff law firm, not an issuer disclosure or a certified court action. Treat as low-signal noise.","key_figures":null,"named_entities":{"people":[{"name":"Corey D. Holzer","role":"Attorney"}],"products":[],"companies":[{"name":"ADMA Biologics, Inc.","ticker":"ADMA"},{"name":"Holzer & Holzer, LLC","relationship":"plaintiff law firm"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-03T19:29:22.912Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":36723,"modelName":"glm-4.7"}}